All news from Anaesthesiology

Loss Of Cilia Leads To Melanoma Research

Melanoma is a deadly type of skin cancer that arises from pigment-forming cells. The article challenges the field by addressing provoking questions in melanoma immunotherapy, cancer systems biology, medical and surgical oncology, pigment biophysics, and precision prevention of skin diseases such as melanoma. The study was published in Pigment Cell & Melanoma Research article, world-leading experts identify emerging frontiers in skin cancer and pigment diseases.

1918 flu pandemic, 100 years on: Lessons to Be Considered

With flu season nearly upon us, a new study looks at the factors behind the extremely high mortality of the 1918 flu pandemic and how to prepare for future outbreaks. The authors warn that while the world is better prepared than 100 years ago, new challenges will affect the impact of the next influenza virus pandemic — including changing population demographics, antibiotic resistance and climate change.

Plant-Rich Diets May Prevent Depression

Data from a clinical trial has shown that how people respond to treatment for Bipolar Disorder may be influenced by their weight and the overall quality of their diet, including whether they are eating a diet high in foods thought to contribute to general inflammation.

These are early results, but if replicated may mean that treatment of some mental health problems could benefit from the inclusion of dietary advice. This is presented at the ECNP Conference in Barcelona.

Rare Metabolic Disorders: New Pre-clinical Research shows Utility of mRNA Platform

Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced new pre-clinical research published in the journal Nature Medicine that further demonstrates the utility of its mRNA platform to express therapeutic levels of protein in liver tissue to potentially treat patients with rare metabolic disorders.

A Simple Way Devised to Boost Efficacy of Malarial TBVs

For decades, scientists have been trying to develop a vaccine that prevents mosquitoes from spreading malaria among humans. This unique approach — in which immunized humans transfer anti-malarial proteins to mosquitoes when bitten — is called a transmission-blocking vaccine (TBV). A few malarial TBVs have shown promise but they have not been widely tested due to unwanted side effects or limited effectiveness.